| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000041 | Transition metal ion transport | Increases phenotype | PMID:21437922; PMID:30496737 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:35643323 |
| GO:0000423 | Mitophagy | Increases phenotype | PMID:36739042 |
| GO:0000724 | Double-strand break repair via homologous recombination | Decreases phenotype | PMID:27449664 |
| GO:0000729 | Dna double-strand break processing | Increases phenotype | PMID:26860703 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:35024197; PMID:35643323; PMID:36849043; PMID:40016168 |
| GO:0001510 | Rna methylation | Affects phenotype | PMID:36739042 |
| GO:0001541 | Ovarian follicle development | Affects phenotype | PMID:24530425 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:25568306 |
| GO:0001678 | Cellular glucose homeostasis | Affects phenotype | PMID:38992767 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:30974164; PMID:36880428; PMID:40016168 |
| GO:0003993 | Acid phosphatase activity | Increases phenotype | PMID:28988497 |
| GO:0003994 | Aconitate hydratase activity | Decreases phenotype | PMID:36108929 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:28988497 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:28988497; PMID:28988497; PMID:30974164; PMID:31756458; PMID:35024197 |
| GO:0004096 | Catalase activity | Increases phenotype | PMID:40016168 |
| GO:0004364 | Glutathione transferase activity | Decreases phenotype | PMID:32679048 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:28988497 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:25846368; PMID:28988497; PMID:32679048 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:28988497; PMID:31756458; PMID:32679048; PMID:35024197; PMID:36108929; PMID:36849043 |
| GO:0006084 | Acetyl-coa metabolic process | Increases phenotype | PMID:32525551 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:32679048 |
| GO:0006090 | Pyruvate metabolic process | Affects phenotype | PMID:32679048 |
| GO:0006302 | Double-strand break repair | Affects phenotype | PMID:25173789 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:38563870 |
| GO:0006306 | Dna methylation | Decreases phenotype | PMID:25846368 |
| GO:0006382 | Adenosine to inosine editing | Decreases phenotype | PMID:31433169 |
| GO:0006601 | Creatine biosynthetic process | Increases phenotype | PMID:30236763 |
| GO:0006703 | Estrogen biosynthetic process | Affects phenotype | PMID:32679048 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:28988497; PMID:32679048; PMID:40016168 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:25448439; PMID:30236763; PMID:31756458 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:30416085 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:14971653; PMID:22858589; PMID:24530425; PMID:24732427; PMID:30416085; PMID:30974164; PMID:35024197; PMID:35307491; PMID:35643323; PMID:36849043 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:31756458; PMID:35024197 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:21481275; PMID:24374135; PMID:26860703 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:35024197; PMID:36108929; PMID:36849043 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:30974164 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:39121936 |
| GO:0008121 | Ubiquinol-cytochrome-c reductase activity | Decreases phenotype | PMID:24732427 |
| GO:0008137 | Nadh dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:24732427; PMID:36108929 |
| GO:0008177 | Succinate dehydrogenase (ubiquinone) activity | Decreases phenotype | PMID:36108929 |
| GO:0008209 | Androgen metabolic process | Affects phenotype | PMID:33675932 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:33675932 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:24374135; PMID:25448439; PMID:27323401; PMID:27344173; PMID:35643323; PMID:38563870 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:25820237; PMID:30715550 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:33675932 |
| GO:0009451 | Rna modification | Affects phenotype | PMID:31433169 |
| GO:0010467 | Gene expression | Affects phenotype | PMID:28596144 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:28077780 |
| GO:0010825 | Positive regulation of centrosome duplication | Increases phenotype | PMID:26293554 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:27793765 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:25448439; PMID:28988497; PMID:30236763; PMID:32679048 |
| GO:0016049 | Cell growth | Increases phenotype | PMID:38992767 |
| GO:0016174 | Nad(p)h oxidase h2o2-forming activity | Increases phenotype | PMID:25448439; PMID:27323401 |
| GO:0016209 | Antioxidant activity | Decreases phenotype | PMID:28077780 |
| GO:0016573 | Histone acetylation | Decreases phenotype | PMID:24858232 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:31756458 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:40016168 |
| GO:0031589 | Cell-substrate adhesion | Decreases phenotype | PMID:38563870 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:36108929; PMID:40016168 |
| GO:0036124 | Histone h3-k9 trimethylation | Increases phenotype | PMID:35643323 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:27323401 |
| GO:0042573 | Retinoic acid metabolic process | Affects phenotype | PMID:32679048 |
| GO:0042743 | Hydrogen peroxide metabolic process | Affects phenotype | PMID:32679048 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:25568306; PMID:29069462 |
| GO:0043966 | Histone h3 acetylation | Increases phenotype | PMID:32525551 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:24732427; PMID:35643323 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:38992767 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:24732427; PMID:36108929 |
| GO:0045833 | Negative regulation of lipid metabolic process | Decreases phenotype | PMID:39121936 |
| GO:0046034 | Atp metabolic process | Increases phenotype | PMID:24732427; PMID:35643323; PMID:36849043 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:36108929 |
| GO:0046601 | Positive regulation of centriole replication | Increases phenotype | PMID:26293554 |
| GO:0046722 | Lactic acid secretion | Affects phenotype | PMID:38992767 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:27323401; PMID:27344173 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:30416085; PMID:30715550; PMID:35643323; PMID:36739042 |
| GO:0055072 | Iron ion homeostasis | Affects phenotype | PMID:24418189 |
| GO:0060723 | Regulation of cell proliferation involved in embryonic placenta development | Affects phenotype | PMID:28077780 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:32679048 |
| GO:0061621 | Canonical glycolysis | Increases phenotype | PMID:32525551 |
| GO:0061739 | Protein lipidation involved in autophagosome assembly | Increases phenotype | PMID:32866567 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:28988497; PMID:28988497; PMID:30974164; PMID:31756458; PMID:36108929; PMID:40016168 |
| GO:0070266 | Necroptotic process | Increases phenotype | PMID:36108929 |
| GO:0070994 | Detection of oxidative stress | Affects phenotype | PMID:25846368; PMID:35024197; PMID:36849043 |
| GO:0070997 | Neuron death | Increases phenotype | PMID:40016168 |
| GO:0071247 | Cellular response to chromate | Decreases phenotype | PMID:31152816 |
| GO:0072582 | 17-beta-hydroxysteroid dehydrogenase (nadp+) activity | Decreases phenotype | PMID:33675932 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:23050433; PMID:24732427; PMID:25448439; PMID:35643323; PMID:36108929; PMID:36368423; PMID:36739042 |
| GO:0080009 | Mrna methylation | Affects phenotype | PMID:35201342 |
| GO:0098658 | Inorganic anion import across plasma membrane | Decreases phenotype | PMID:25977998 |
| GO:0102727 | 3beta-hydroxysteroid dehydrogenase activity | Decreases phenotype | PMID:33675932 |
| GO:0106292 | Superoxide-generating nadph oxidase activity | Increases phenotype | PMID:27344173 |
| GO:1900409 | Positive regulation of cellular response to oxidative stress | Increases phenotype | PMID:28077780 |
| GO:1901382 | Regulation of chorionic trophoblast cell proliferation | Affects phenotype | PMID:28077780 |
| GO:1901525 | Negative regulation of mitophagy | Increases phenotype | PMID:30715550 |
| GO:1901526 | Positive regulation of mitophagy | Increases phenotype | PMID:32866567 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:35643323 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:27323401; PMID:28881718; PMID:30236763 |
| GO:1903703 | Enterocyte differentiation | Affects phenotype | PMID:38563870 |
| GO:1905037 | Autophagosome organization | Increases phenotype | PMID:36739042 |
| GO:1905168 | Positive regulation of double-strand break repair via homologous recombination | Increases phenotype | PMID:38867691 |
| GO:1905707 | Negative regulation of mitochondrial atp synthesis coupled proton transport | Increases phenotype | PMID:30715550 |
| GO:1990266 | Neutrophil migration | Increases phenotype | PMID:36880428 |
| GO:2000781 | Positive regulation of double-strand break repair | Increases phenotype | PMID:25288669 |
| GO:2001022 | Positive regulation of response to dna damage stimulus | Affects phenotype | PMID:25173789 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.